About 500 reports

  • DEBT OFFERING
  • Shanxi Zhendong Pharma to Raise USD188 Million in Public Offering of Shares Equity Offering

GlobalData Shanxi Zhendong Pharmaceutical Co Ltd' s, deal volume decreased from one pharmaceuticals & healthcare deal in 2016 to zero pharmaceuticals & healthcare deals in 2017.

  • Pharmaceutical
  • China
  • Company
  • Corporate Finance
  • Deals & Alliance
  • Advisor Information Company Being Advised
  • Deal Type

Completed ##-for-## reverse stock split.

  • Pharmaceutical
  • United States
  • Company
  • Corporate Finance
  • Ritter Pharmaceuticals, Inc.
  • Assembly Biosciences Completes Underwriters Exercise of Over-Allotment of Public Offering of Shares
  • Deal Type

GlobalData Assembly Biosciences Inc reported one pharmaceuticals & healthcare deal worth $##. ## million in YTD 2018.

  • Pharmaceutical
  • United States
  • Company
  • Corporate Finance
  • Assembly Biosciences, Inc.

One study recruits children as young as one year old with a particularly aggressive form of neuroblastoma.

  • Pharmaceutical
  • United States
  • Corporate Finance
  • Product Initiative
  • Protalex, Inc.
  • Deal Type

It provides tests for infections of the bloodstream, respiratory tract and gastrointestinal tract.

  • Bionanotechnology
  • Medical Device
  • Nanobiotechnology
  • Corporate Finance
  • Nanosphere, Inc.
  • Deal Type

The company offers drugs for various therapeutic areas such as antibiotics, antibacterial, gastrointestinal, psychotropic, antiviral, immunomodulation, antiallergic and traditional Chinese medicine.

  • Healthcare
  • Pharmaceutical
  • Corporate Finance
  • Deals & Alliance
  • M&A

GlobalData Deal Type Acquisition Asset Purchases Debt Offerings Equity Offerings Licensing Agreement No. of Deals ## ## ## ## ## Deal Value (US$ million) NA NA ##. ## ##. ## NA Pivot Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 P

  • Pharmaceutical
  • Company
  • Corporate Finance
  • Deals & Alliance
  • M&A

All Regado shares will be subject to the nine for one reverse stock split.

  • Therapy
  • United States
  • Company
  • Corporate Finance
  • Tobira Therapeutics, Inc.

Each unit comprised of one common share and one warrant.

  • Ear Disease
  • Therapy
  • Company
  • Corporate Finance
  • Auris Medical Holding AG

Penta is one of significant players in the healthcare sector in the CEE.

  • Health Services
  • Corporate Finance
  • Deals & Alliance
  • M&A
  • Emc Instytut Medyczny SA
  • XENOPORT COMPLETES PUBLIC OFFERING OF COMMON STOCK FOR US$46 MILLION
  • DEBT OFFERING

The company' s generic products are used for the treatment of conditions such as gastrointestinal disorders, oncology, cardiovascular diseases, pain management, Central Nervous System, cancer, pain, infectious diseases and pediatrics.

  • Healthcare
  • Pharmaceutical
  • Corporate Finance
  • Demand
  • XenoPort, Inc.
  • Relypsa Completes IPO For US$86.7 Million

Relypsa will fund the grant awards of up to $##, ## each for one academic year.

  • Healthcare
  • Pharmaceutical
  • Company
  • Corporate Finance
  • Relypsa, Inc.

Virobay Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 Virobay Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 Virobay Inc reported one pharmaceuticals & healthcare deals each in equity offerings, licensing agreement and venture financing du

  • Healthcare
  • Pharmaceutical
  • Company
  • Corporate Finance
  • Virobay Inc.

Interest on the notes is payable semi-annually on April ## and October ## of each year, beginning from October ##, 2013.

  • Healthcare
  • Pharmaceutical
  • Therapy
  • Corporate Finance
  • Medtronic, Inc.

The debentures bear an interest rate of ##% per annum payable monthly, and will mature on January ##, 2015.

  • Opioid
  • Pharmaceutical
  • United States
  • Corporate Finance
  • Intellipharmaceutics International Inc.

Oncology Ophthalmology Other Diseases Pharmaceuticals and Healthcare Respiratory Women' s Health ## ## ## ## ## ## Note: Deals include all announced pharmaceuticals & healthcare deals from 2012 onwards, deal values included wherever disclosed.

  • Pharmaceutical
  • United States
  • Company
  • Corporate Finance
  • Optinose US Inc.

It inhibits hypoxia inducible factor ## (HIF-##) alpha and topoisomerase I.

  • Pharmaceutical
  • United States
  • Company
  • Corporate Finance
  • Cerulean

Each unit consists of one share of common stock and one warrant to purchase one half share of common stock.

  • Cell Therapy
  • Healthcare
  • United States
  • Company
  • Corporate Finance

Each unit consists of one share of the company' s common stock and one warrant to purchase ##. ## of a share of common stock.

  • Healthcare
  • Therapy
  • Company
  • Corporate Finance
  • Pluristem Therapeutics Inc.

The company reported one pharmaceuticals & healthcare deal each in 2016 and 2017.

  • Healthcare
  • Pharmaceutical
  • Company
  • Corporate Finance
  • Aquinox Pharmaceuticals, Inc.

Hemorrhoids are a common gastrointestinal disorder characterized by pain, swelling, itching, tenderness, and bleeding.

  • Pharmaceutical
  • Therapy
  • United States
  • Corporate Finance
  • Citius Pharmaceuticals, Inc.

Each Unit consists of one common share and one share purchase warrant.

  • Healthcare
  • Pharmaceutical
  • Therapy
  • Corporate Finance
  • Sunovion Pharmaceuticals Inc.

GlobalData Omega Pharma NV, reported one pharmaceuticals & healthcare deal in YTD 2018.

  • Pharmaceutical
  • Company
  • Corporate Finance
  • M&A
  • Omega

Each unit consists of one common share and one share purchase warrant.

  • Therapy
  • Company
  • Company Financials
  • Corporate Finance
  • TTI

To create one dynamic headquarters facility, Innovation One will include a two-story link connecting the structure to Exact Sciences' existing ##, ## square foot research facility at ## Charmany Drive.

  • Healthcare
  • Pharmaceutical
  • United States
  • Corporate Finance
  • Exact Sciences Corp.

GlobalData Huons Global Co Ltd' s, deal volume decreased from one pharmaceuticals & healthcare deal in 2016 to zero pharmaceuticals & healthcare deals in 2017.

  • Pharmaceutical
  • World
  • Corporate Finance
  • Deals & Alliance
  • Huons Global Co Ltd

Each unit consists of one common share and one share purchase warrant.

  • Therapy
  • Company
  • Company Financials
  • Corporate Finance
  • TTI

The notes have a coupon rate of ##. ##% with a term period of one year.

  • Pharmaceutical
  • Corporate Finance
  • Deals & Alliance
  • M&A
  • Tasly Pharmaceutical Group Co., Ltd.

GlobalData Celltrion Inc reported one pharmaceuticals & healthcare deal in YTD 2018.

  • Healthcare
  • Pharmaceutical
  • Therapy
  • Corporate Finance
  • Celltrion, Inc.

GlobalData Natco Pharma Ltd, reported one pharmaceuticals & healthcare deal each in 2016 and 2017.

  • Healthcare
  • Pharmaceutical
  • Company
  • Corporate Finance
  • Natco Pharma Limited